Liu et al. demonstrated that miR-221 promotes TGFβ1-induced EMT in human bladder cancer cells by targeting STMN1, positioning it as a promising therapeutic target for metastasis (Liu et al., 2015). The gene discussed is STMN1; the disease is urinary bladder carcinoma.